Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)

View ORCID ProfileJackrapong Bruminhent, Chavachol Sethaudom, Pongsathon Chaumdee, Sarinya Boongird, Sasisopin Kiertiburanakul, Kumthorn Malathum, Arkom Nongnuch, Angsana Phuphuakrat, Sopon Jirasiritham, Chitimaporn Janphram, Sansanee Thotsiri, Supparat Upama, Montira Assanatham, Ramathibodi Transplant Infectious Diseases (RTID) Study Group
doi: https://doi.org/10.1101/2021.08.02.21261095
Jackrapong Bruminhent
1Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2Excellence Center for Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jackrapong Bruminhent
Chavachol Sethaudom
3Immunology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pongsathon Chaumdee
4Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarinya Boongird
2Excellence Center for Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
5Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sasisopin Kiertiburanakul
1Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kumthorn Malathum
1Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arkom Nongnuch
2Excellence Center for Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
5Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angsana Phuphuakrat
1Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sopon Jirasiritham
2Excellence Center for Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
6Division of Vascular and Transplant Surgery, Department of Surgery, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
7Praram 9 Hospital, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chitimaporn Janphram
8Somdech Phra Debaratana Medical Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sansanee Thotsiri
8Somdech Phra Debaratana Medical Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Supparat Upama
9Samitivej Hospital Sukhumvit, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Montira Assanatham
2Excellence Center for Organ Transplantation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
5Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: montira.asa@mahidol.ac.th
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Immunogenicity following inactivated SARS-CoV-2 vaccination among solid organ transplant recipients has not been assessed. Seventy-five patients (37 kidney transplant [KT] recipients and 38 non-transplant controls) received two doses, at 4-week intervals, of an inactivated whole-virus SARS-CoV-2 vaccine. SARS-CoV-2-specific humoral (HMI) and cell-mediated immunity (CMI) were measured before, 4 weeks post-first dose, and 2 weeks post-second dose. The median age of KT recipients was 50 years (IQR, 42–54) and 89% were receiving calcineurin inhibitors/mycophenolate/corticosteroid regimens. The median time since transplant was 4.5 years (IQR, 2–9.5). Among 35 KT patients, anti-RBD IgG titer after vaccination was not significantly different to baseline, but was significantly lower than in controls (7.8 [95%CI 0.2–15.5] vs 2,691 [95%CI 1,581–3,802], p<0.001) as well as the percentage of surrogate virus neutralizing antibody inhibition (2 [95% CI −1-6] vs 71 [95%CI 61–81], p<0.001). However, the mean of SARS-CoV-2 mixed peptides-specific T-cell responses measured by enzyme-linked immunospot assays was significantly increased compared with baseline (66 [95%CI 36–99] vs. 34 [95%CI 19–50] T-cells/106 PBMCs, p=0.02) and comparable to that in controls. Our findings revealed weak HMI and marginal CMI responses in fully vaccinated KT recipients receiving inactivated SARS-CoV-2 vaccine. (Thai Clinical Trials Registry, TCTR20210226002).

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Thai Clinical Trials Registry, TCTR20210226002.

Funding Statement

This study received a grant from the National Research Council of Thailand (NRCT), Ministry of Higher Education, Science, Research, and Innovation of Thailand in collaboration with the Department of Medical Services, Ministry of Public Health of Thailand (102912).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All patients provided written consent. The Institutional Review Board of the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, reviewed and approved the study protocol (approval number: MURA2021/242).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be made available upon appropriate request.

  • Abbreviations

    ACE2
    angiotensin-converting enzyme 2
    AE
    adverse events
    CI
    confidence interval
    CMI
    SARS-CoV-2-specific cell-mediated immunity
    COVID-19
    coronavirus disease 2019
    ELISpot
    enzyme-linked immunospot assay
    HMI
    SARS-CoV-2-specific humoral immunity
    IFN-γ
    interferon-γ
    IgG
    immunoglobulin G
    IQR
    interquartile range
    KT
    kidney transplant
    M
    SARS-CoV-2 membrane protein
    mRNA
    messenger ribonucleic acid
    N
    SARS-CoV-2 nucleoprotein
    ORF
    open reading frame
    PBMC
    peripheral blood mononuclear cell
    RBD
    receptor binding domain
    RT-PCR
    reverse-transcription polymerase chain reaction
    S
    SARS-CoV-2 spike glycoprotein
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2 SFU spot forming units
    SMNO
    SARS-CoV-2 spike protein, nucleoprotein, membrane protein and ORF-3a, and ORF-7a proteins
    SOT
    solid organ transplantation
    sVNT
    SARS-CoV-2 surrogate virus neutralization test
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted August 04, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)
    Jackrapong Bruminhent, Chavachol Sethaudom, Pongsathon Chaumdee, Sarinya Boongird, Sasisopin Kiertiburanakul, Kumthorn Malathum, Arkom Nongnuch, Angsana Phuphuakrat, Sopon Jirasiritham, Chitimaporn Janphram, Sansanee Thotsiri, Supparat Upama, Montira Assanatham, Ramathibodi Transplant Infectious Diseases (RTID) Study Group
    medRxiv 2021.08.02.21261095; doi: https://doi.org/10.1101/2021.08.02.21261095
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)
    Jackrapong Bruminhent, Chavachol Sethaudom, Pongsathon Chaumdee, Sarinya Boongird, Sasisopin Kiertiburanakul, Kumthorn Malathum, Arkom Nongnuch, Angsana Phuphuakrat, Sopon Jirasiritham, Chitimaporn Janphram, Sansanee Thotsiri, Supparat Upama, Montira Assanatham, Ramathibodi Transplant Infectious Diseases (RTID) Study Group
    medRxiv 2021.08.02.21261095; doi: https://doi.org/10.1101/2021.08.02.21261095

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (215)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1093)
    • Dentistry and Oral Medicine (195)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
    • Epidemiology (9758)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2304)
    • Geriatric Medicine (222)
    • Health Economics (462)
    • Health Informatics (1554)
    • Health Policy (732)
    • Health Systems and Quality Improvement (602)
    • Hematology (236)
    • HIV/AIDS (501)
    • Infectious Diseases (except HIV/AIDS) (11634)
    • Intensive Care and Critical Care Medicine (616)
    • Medical Education (236)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2140)
    • Nursing (134)
    • Nutrition (335)
    • Obstetrics and Gynecology (426)
    • Occupational and Environmental Health (517)
    • Oncology (1172)
    • Ophthalmology (363)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (309)
    • Pediatrics (694)
    • Pharmacology and Therapeutics (298)
    • Primary Care Research (265)
    • Psychiatry and Clinical Psychology (2173)
    • Public and Global Health (4648)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (455)
    • Respiratory Medicine (623)
    • Rheumatology (274)
    • Sexual and Reproductive Health (225)
    • Sports Medicine (210)
    • Surgery (250)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)